Analogic CEO Green steps away | Personnel Moves Nov 4, 2016
Analogic (NSDQ:ALOG) said late last month its prez and CEO James Green has stepped away from his position to pursue other opportunities. Company director and former Enovate Medical exec chair and CEO...
View ArticleHemodialysis dev InnAVasc raises $2.2m
InnAVasc Medical said it raised $2.15 million in a new round of equity financing, according to an SEC filing posted today . InnAVasc is developing devices designed for vascular access during...
View ArticleReshaped Philips targets higher sales and improved margins
(Reuters) – Royal Philips (NYSE:PHG), the healthcare equipment and services company, said it expects 4-6% sales growth and a 1% improvement in margins annually over the next few years. The mid-term...
View ArticleUpdate on Brazil’s new ownership transfer rules for medical device registrants
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: ANVISA has clarified its ownership transfer rules for corporate operations such as mergers and incorporations of companies registered to...
View ArticleMedtronic joins Masimo CEO Kiani’s Patient Safety Foundation, pledges $5m
Despite being rivals in the blood oxygen diagnostic fields, Medtronic (NYSE:MDT) said it is joining Masimo (NSDQ:MASI) CEO Joe Kiani’s Patient Safety Movement Foundation with a $5 million, 5-year...
View ArticleBoston Scientific, University of Alabama settle CRM patent spat
Boston Scientific (NYSE:BSX) and the University of Alabama settled a patent dispute over cardiac rhythm management technology. The spat spans back to 2014, when the University of Alabama at Birmingham...
View ArticleCMS acting chief Slavitt slams drug pricing
Centers for Medicare & Medicaid Services acting chief Andy Slavitt admonished pharma companies like Mylan (NSDQ:MYL) over unsustainable price increases before the Biopharma Congress in Washington...
View ArticleAbbott wins Japanese approval for Absorb
Abbott (NYSE:ABT) said today it won approval from the Japanese Ministry of Health, Labor and Welfare for its Absorb bioresorbable heart stent, touting it as the 1st fully dissolving heart stent...
View ArticlePropeller wins FDA nod for connected GSK Ellipta inhaler
Propeller Health said today that it won 510(k) clearance from the FDA to market its Propeller platform with GlaxoSmithKline‘s (NYSE:GSK) Ellipta inhaler. A sensor for the dry powder inhaler was built...
View ArticleSt. Jude wins CE Mark for MRI safe labeling for Quadra CRT-P
St. Jude Medical (NYSE:STJ) said today it won CE Mark approval in the European Union to add magnetic resonance imaging conditional labeling to its Quadra Allure MP cardiac resynchonization therapy...
View ArticlePAVmed partners with Boston institutions for antibiotic-eluting ear device
PAVmed Inc. (NSDQ:PAVMU) said today that it inked an exclusive licensing agreement with academic institutions to develop and commercialize antibiotic-eluting resorbable ear tubes based on an aqueous...
View ArticleMedical device tax rears its head in more Congressional races
Despite not getting much coverage during the U.S. presidential race, the Medical Device tax has become a hot topic for a handful of Congressional races across the country. The 2.3% medical device tax,...
View ArticleClinton Foundation emails link BD with Russian program
A recently uncovered batch of emails related to the Clinton Foundation indicate that the group sought aid from medtech firm Becton Dickinson & Co. (NYSE:BDX) in helping the Russian Ministry of...
View ArticleFirst patient receives Pixium bionic vision implant
Pixium Vision (EPA:PIX) said today that the 1st patient in the UK was implanted with its IRIS II bionic vision system. The epi-retinal implant has 150 electrodes and a bio-inspired camera intended for...
View ArticleFlamel Technologies tops Q3 revenue, EPS estimate
Shares in Flamel Technologies (NSDQ:FLML) rose today after the pharmaceutical company met expectations on Wall Street with its 3rd quarter results. The Venissieux, France-based company posted a loss of...
View ArticleMassDevice.com +5 | The top 5 medtech stories for November 7, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticlePhilips settles with Masimo for $300m, inks patient monitoring partnership
Masimo (NSDQ:MASI) said today that Royal Philips (NYSE:PHG) agreed to pay $300 million to resolve all outstanding legal disputes between the companies, with both inking a multi-year patient monitoring...
View ArticleSiemens picks up point-of-care interface dev Conworx Tech
Siemens Healthineers (NYSE:SI) said today it acquired Berlin-based point-of-care device interface and data management developer Conworx Technology for an undisclosed amount. Siemens will pick up...
View ArticleResearchers stunt growth of ovarian cancer with nanohydrogels
Researchers at the Georgia Institute of Technology have developed a targeted therapy using nanohydrogels to stunt the growth of ovarian tumors in in vivo tests in mice, according to a new study. The...
View ArticleBiotronik launches high energy Inventra HF-T ICD
Biotronik said today it launched the “ultra-high” energy Inventra HF-T, touting it as the 1st and only implantable cardioverter defibrillator available to deliver 42 joules in the 1st shock. The new...
View Article